Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2008 | 03-2007 | 03-2006 | 03-2005 | 03-2004 | |
| Sales | 0 | 0 | 22,354 | 24,287 | 21,541 |
| Cost of Goods | N/A | N/A | 15,113 | 14,581 | 12,846 |
| Gross Profit | N/A | N/A | 7,241 | 9,706 | 8,695 |
| Operating Expenses | 3,063 | 2,762 | 8,475 | 9,001 | 8,574 |
| Operating Income | -3,063 | -2,762 | -1,121 | 1,286 | 967 |
| Interest Expense | 1,480 | 5 | 0 | 0 | 0 |
| Other Income | 27 | 62 | 17 | 41 | 34 |
| Pre-tax Income | -4,516 | -2,705 | -1,104 | 1,327 | 1,001 |
| Income Tax | 4 | 992 | -431 | -484 | N/A |
| Net Income Continuous | -4,520 | -3,697 | -673 | 1,811 | 1,001 |
| Net Income Discontinuous | -4,083 | 283 | N/A | N/A | N/A |
| Net Income | $-8,603 | $-3,414 | $-673 | $1,811 | $1,001 |
| EPS Basic Total Ops | -0.85 | -0.34 | -0.07 | 0.18 | 0.10 |
| EPS Basic Continuous Ops | -0.45 | -0.36 | -0.07 | 0.18 | 0.10 |
| EPS Basic Discontinuous Ops | -0.40 | 0.02 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.85 | -0.34 | -0.07 | 0.17 | 0.10 |
| EPS Diluted Continuous Ops | -0.45 | -0.36 | -0.07 | 0.17 | 0.10 |
| EPS Diluted Discontinuous Ops | -0.40 | 0.02 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.19 | -0.07 | 0.17 | 0.10 |
| EBITDA(a) | $-2,323 | $-2,370 | $-663 | $1,703 | $1,417 |